Sign Up Today and Learn More About Torigen Pharmaceuticals Stock
Invest in or calculate the value of your shares in Torigen Pharmaceuticals or other pre-IPO companies through EquityZen's platform.
Torigen Pharmaceuticals Stock (TORP)
Torigen Pharmaceuticals focuses on providing cancer care solutions for animals.
About Torigen Pharmaceuticals Stock
Founded
2013
Headquarters
Farmington, CT, US
Industries
Science and Engineering, Health Care, Biotechnology
Torigen Pharmaceuticals Press Mentions
Stay in the know about the latest news on Torigen Pharmaceuticals
Immune memory enhanced preparations and uses thereof
patents • Apr 02, 2025
DRAP issues immediate recall alert for substandard pharma products
brecorder • Mar 29, 2025
Torigen Launches Specialty Pathology Service To Deliver Expert Cancer Diagnoses For Pets
prweb • Dec 10, 2024
Immune memory enhanced preparations and uses thereof
patents • Apr 15, 2024
Pet Cancer Therapeutics Market Analysis, Trends, Growth, Research And Forecast 2032
openpr • Dec 22, 2023
Torigen Pharmaceuticals Management
Leadership team at Torigen Pharmaceuticals
CFO
John Kallassy
Founder & CEO
Ashley Kalinauskas
Join now and verify your accreditation status to gain access to:
- Torigen Pharmaceuticals Current Valuation
- Torigen Pharmaceuticals Stock Price
- Torigen Pharmaceuticals Management
- Available deals in Torigen Pharmaceuticals and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Torigen Pharmaceuticals Cap Table and Funding History by Share Class and Liquidity Preferences
- Torigen Pharmaceuticals Revenue and Financials
- Torigen Pharmaceuticals Highlights
- Torigen Pharmaceuticals Business Model
- Torigen Pharmaceuticals Risk Factors
- Torigen Pharmaceuticals Research Report from SACRA Research
Trading Torigen Pharmaceuticals Stock
How to invest in Torigen Pharmaceuticals stock?
Accredited investors can buy pre-IPO stock in companies like Torigen Pharmaceuticals through EquityZen funds. These investments are made available by existing Torigen Pharmaceuticals shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Torigen Pharmaceuticals stock?
Shareholders can sell their Torigen Pharmaceuticals stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
